Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

E-ISSN： 2212-3946|10|2|181-187

ISSN： 1574-888x

Source： Current Stem Cell Research & Therapy, Vol.10, Iss.2, 2015-01, pp. : 181-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-03 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Cancer Therapy Updates

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 954-966

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Targeting of Endothelial Progenitor Cells

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 10, Iss. 1, 2010-03 ,pp. : 16-32

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Promises and pitfalls of anti-angiogenic therapy in clinical trials

By McCarty M.F. Liu W. Fan F. Parikh A. Reimuth N. Stoeltzing O. Ellis L.M.

Trends in Molecular Medicine, Vol. 9, Iss. 2, 2003-02 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite